Dakota Wealth Management Buys Shares of 3,632 Plexus Corp. $PLXS

Dakota Wealth Management bought a new position in Plexus Corp. (NASDAQ:PLXS) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 3,632 shares of the technology company’s stock, valued at approximately $534,000.

Several other hedge funds have also recently modified their holdings of the business. Salomon & Ludwin LLC purchased a new stake in shares of Plexus during the third quarter valued at $30,000. Allworth Financial LP raised its position in Plexus by 70.1% in the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after buying an additional 103 shares during the last quarter. Johnson Financial Group Inc. purchased a new position in Plexus in the 3rd quarter worth about $72,000. EverSource Wealth Advisors LLC lifted its stake in Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after acquiring an additional 490 shares during the period. Finally, Smartleaf Asset Management LLC boosted its holdings in shares of Plexus by 33.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 806 shares of the technology company’s stock valued at $115,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Price Performance

NASDAQ PLXS opened at $192.97 on Tuesday. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $220.17. The firm has a market capitalization of $5.17 billion, a P/E ratio of 30.01 and a beta of 0.81. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The company has a 50-day moving average price of $195.86 and a 200-day moving average price of $165.09.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The firm’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Equities research analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.

Insider Buying and Selling at Plexus

In related news, Chairman Dean A. Foate sold 5,000 shares of the firm’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $204.89, for a total value of $1,024,450.00. Following the transaction, the chairman directly owned 15,000 shares of the company’s stock, valued at approximately $3,073,350. This trade represents a 25.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Patrick John Jermain sold 4,841 shares of Plexus stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $204.01, for a total value of $987,612.41. Following the transaction, the chief financial officer owned 20,469 shares in the company, valued at $4,175,880.69. This trade represents a 19.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 49,495 shares of company stock worth $10,009,836. Insiders own 1.78% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on PLXS shares. Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 6th. Benchmark restated a “buy” rating and set a $220.00 price objective on shares of Plexus in a research report on Monday, March 16th. Williams Trading set a $195.00 target price on shares of Plexus in a report on Wednesday, January 28th. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research report on Sunday, March 8th. Finally, Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Plexus currently has an average rating of “Moderate Buy” and a consensus target price of $194.20.

Plexus Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.